Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial-Reference-Cited by-同舟云学术

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Published:2013-07-22 Issue:6 Volume:63 Page:919-927
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Steenholdt Casper,Brynskov Jørn,Thomsen Ole Østergaard,Munck Lars Kristian,Fallingborg Jan,Christensen Lisbet Ambrosius,Pedersen Gitte,Kjeldsen Jens,Jacobsen Bent Ascanius,Oxholm Anne Sophie,Kjellberg Jakob,Bendtzen Klaus,Ainsworth Mark Andrew

Publisher

BMJ

Subject

Gastroenterology

Reference26 articles.

1. Management of Crohn's disease in adults;Lichtenstein;Am J Gastroenterol,2009

2. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis;Ford;Am J Gastroenterol,2011

3. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management;Dignass;J Crohns Colitis,2010

4. Guidelines for the management of inflammatory bowel disease in adults;Mowat;Gut,2011

5. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?;D'Haens;Am J Gastroenterol,2011

Cited by 410 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

2. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

3. Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial;BMJ Open;2024-07

4. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment;Journal of Crohn's and Colitis;2024-06-15

5. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study;The Lancet Gastroenterology & Hepatology;2024-06